Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02638298 · ClinicalTrials.gov registry record · NA

Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma Wounds

A NA study of Cancer and Sarcoma, sponsored by Medical University of South Carolina.

Completed
Registry status
NA
Development phase
163
Enrollment target
1
Study location

NCT02638298 is a NA study of Cancer and Sarcoma that has completed, run by Medical University of South Carolina. The registered enrollment target is 163 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02638298, a NA study of Cancer and Sarcoma, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
NA
Development phase
163 participants
Enrollment target
1
Study location

Study Summary

This is a study comparing two methods of dressing a post operative wound that are currently in practice. One method is a traditional dry gauze dressing. The other method is using a negative pressure dressing that provides gentle suction on the wound. The investigators will attempt to determine how well the use of post-operative negative pressure dressing reduces wound healing problems in patients who have surgery after radiation for a sarcoma in the thigh or leg.

Interventions

  • DEVICE Prevana Dressing
  • OTHER Standard Dry Gauze Dressing

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 163 participants
Start Date 2015-12
Est. Completion 2024-07
Phase NA

What the Registry Record Tells You About NCT02638298

The ClinicalTrials.gov registry entry for NCT02638298 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 163 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (95% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Prevana Dressing is the first listed.

NCT02638298 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT02638298 about?

NCT02638298 is a clinical study titled "Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma Wounds". This is a study comparing two methods of dressing a post operative wound that are currently in practice. One method is a traditional dry gauze dressing. The other method is using a negative pressure dressing that provides gentle suction on the wound. The investigators will attempt to determine how ...

What is the current status of trial NCT02638298?

This trial is currently completed. It is a NA study. The enrollment target is 163 participants. The study started on 2015-12. Estimated completion is 2024-07.

What conditions does trial NCT02638298 study?

This clinical trial studies the following conditions: Cancer, Sarcoma, Infectious Disease.

What interventions are being tested in trial NCT02638298?

The interventions under investigation include: Prevana Dressing (DEVICE), Standard Dry Gauze Dressing (OTHER).

Who is sponsoring clinical trial NCT02638298?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02638298 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.